SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solidion Technology, Inc. engages in researching, developing and manufacturing battery components and materials, batteries and related energy storage products for the automotive electric vehicle and other markets. The company was founded on June 30, 2023 and is headquartered in Dallas, TX.

Solidion Technology Inc

Solidion Technology is experiencing significant market attention and volatility driven by its recent patent disclosures and strategic pivot into the space and AI-energy infrastructure sectors, particularly as investors speculate on potential synergies with SpaceX. While the community is actively debating the stock's massive short interest and the potential for a short squeeze, many are focused on whether the company will manage its capital effectively or initiate further equity offerings.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is experiencing heightened volatility driven by geopolitical escalation in the Middle East and concerns over a potential burst in the AI-driven tech bubble. Community sentiment is deeply divided, with traders closely monitoring the impact of foreign market instability, oil price fluctuations, and high-stakes government diplomacy on market direction.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure is trending as investors weigh an upsized 400 million convertible note offering against high expectations for imminent hyperscaler data center contracts. While some community members worry about the optics of raising capital, many bulls view the move as a bullish signal that the company is aggressively funding expansion to meet massive AI energy demand.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors react to a significant earnings beat and a new multibillion-dollar share buyback authorization, with many in the community debating whether these developments provide enough momentum to trigger a short squeeze. Meanwhile, ongoing discussions focus on Ryan Cohen's strategic accumulation of eBay shares and widespread frustration regarding alleged market manipulation and synthetic share suppression.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF is trending as investors aggressively build positions in the memory supply chain, fueled by record-breaking valuation milestones for key components like SK Hynix and Micron. Community discussion is dominated by the belief that a structural, long-term shortage of HBM and DRAM will continue to drive demand, leading many to use this ETF as a consolidated play to gain exposure to the critical infrastructure backing AI compute.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing significant momentum as investors increasingly recognize the critical role of its QNX operating system in powering the expanding Physical AI and robotics sectors. The community is actively discussing the stock's transition from a legacy name to a vital infrastructure player in autonomous systems, often highlighting long-term conviction in the company's foundational safety and security technology.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market participants are weighing the implications of heightened geopolitical tensions in the Middle East alongside the looming SpaceX IPO, creating significant uncertainty and volatility across tech-heavy indices. The community is actively debating whether recent pullbacks represent a healthy buying opportunity driven by AI infrastructure spending or the early stages of a broader bubble correction.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors digest the company's aggressive acquisition strategy, including a series of deals to bolster its infectious disease vaccine portfolio, alongside strong sentiment regarding the clinical success and growth trajectory of its GLP-1 weight-loss franchise. Community sentiment remains largely bullish, focusing on the company's ability to maintain a competitive lead through pipeline depth and strategic partnerships despite ongoing sector-wide price pressures and market rotation.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing a significant sell-off as investors pull back from high-flying AI and semiconductor stocks amid concerns over rising Treasury yields, hot jobs data, and broader macroeconomic uncertainty. The community is actively debating whether this is a healthy consolidation within a long-term bull market or the long-anticipated popping of an AI-driven bubble.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs (PL) shares are experiencing heightened volatility and intense community discussion following a strategic $1.5 billion 'at-the-market' offering, which investors are weighing against strong recent earnings and rising institutional price targets. The stock remains a focal point for traders navigating the broader space sector, as community sentiment is deeply divided between those viewing the pullback as a generational buying opportunity and others concerned about near-term dilution pressure ahead of the upcoming SpaceX IPO.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates

Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of -51.23% and -98.27%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates

Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of +10.70% and +150.00%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of +26.63% and +294.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

Bolt Biotherapeutics (BOLT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates

Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of +30.31% and +73.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates

ANI (ANIP) delivered earnings and revenue surprises of +30.43% and +12.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals (PHAT) delivered earnings and revenue surprises of -3.95% and +8.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates

Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.

BOLTBolt Biotherapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BOLT News